Formulation Scientist III
Quotient Sciences
Kyle Frey is a medically trained formulation scientist leading early phase formulation design projects at Quotient Sciences. Kyle developed a passion for finding creative solutions to challenging problems early in his career, where at DowDuPont he spearheaded the first successful development of oral thin films for drug delivery applications. After being awarded an innovation grant for his vision of using new and alternative technology to accelerate the drug development cycle and enhance the quality of manufactured products, Kyle would later achieve world class results through his breakthroughs in low-dose mixing. He has prepared a pentology of original research articles based on his research, with the first recently accepted by Pharmaceutical Research 16 October 2023 and available online now. He looks forward to continuing to share his experience and knowledge early and mid-2024 with the remaining set of publications, and to keep seeking the most cutting-edge technology in deliverance of Quotient's core drives to assess, adapt and accelerate patient care.